scispace - formally typeset
P

Paul J. van Diest

Researcher at Utrecht University

Publications -  514
Citations -  22750

Paul J. van Diest is an academic researcher from Utrecht University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 70, co-authored 459 publications receiving 18892 citations. Previous affiliations of Paul J. van Diest include University Medical Center Utrecht & VU University Medical Center.

Papers
More filters
Journal ArticleDOI

HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor

TL;DR: HIF-1α overexpression is an indicator of favourable prognosis in T1 and T2 SCC of the oral floor and node negative patients lacking HIF- 1α expression may therefore be considered for adjuvant radiotherapy.
Journal Article

Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model

TL;DR: In this article, the effect of intrahepatic I/R on the outgrowth of pre-established colorectal micrometastases in a highly standardized murine model and the putative protective effect of alternative clamping methods were evaluated.
Journal ArticleDOI

Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance

TL;DR: It is shown here that cytosolic p120-catenin (p120) regulates tumor growth upon loss of E-cadherin through the induction of anoikis resistance, and this insight may have clinical implications for the development of tailor-made intervention strategies to better treat invasive and metastatic lobular breast cancer.
Journal ArticleDOI

Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high‐molecular‐weight cytokeratin expression patterns

TL;DR: Comparative genomic hybridization was used to screen ductal hyperplasia and other BPBD lesions and ductal carcinoma in situ (DCIS) for common genomic abnormalities, to test the relationship between these hyperplastic and neoplastic lesions and support the view thatBPBD and DCIS are not closely related entities and that BPBD is not an obligate direct precursor of DCIS.
Journal ArticleDOI

Molecular subtyping of male breast cancer by immunohistochemistry

TL;DR: Most male breast cancers are luminal A and luminal B types, whereas basal-like, unclassifiable triple-negative, and HER2 driven male breast cancer are rare.